Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 10.5610.988.726.2411.72

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.56 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24
Mar202111.72

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24
-46.76
Mar2021 11.72 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹130.7 Cr 0.3% -5.3% -51.7% Stock Analytics
ADANI ENTERPRISES ₹418,130.0 Cr 8.4% 9.8% 26.8% Stock Analytics
PREMIER ENERGIES ₹47,481.1 Cr 1.6% -3.9% 0.8% Stock Analytics
AEGIS LOGISTICS ₹46,530.3 Cr 13% 74.4% 59.1% Stock Analytics
ADITYA INFOTECH ₹42,328.4 Cr -3.3% 6.7% NA Stock Analytics
REDINGTON ₹21,487.1 Cr -0.3% 13.4% -6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

0.3%

-5.3%

-51.7%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses